Juvo latin; help, assist, aid, support, serve, further + Lab where great ideas are born
NOW AVAILABLE: Oncology Community Twitter Dialogue: ASCO 2010. Key insights in compliant healthcare social media practice
Pioneering 49-page report and strategic analysis. Official Press Release July 15, 2010
More details and how to order
More details and how to order
Report mentions on... TheStreet Reuters MarketWatch AOL Finance Yahoo Finance Pharmaceutical Industry Today Forbes
JuvoLab is proud to provide copies of the report free of charge to Non-Profit Organizations.
"The JuvoLab #ASCO10 report contains a lot of useful information. Some of it is consistent with my subjective experience, but there were also a few surprises in there. I didn't realize that a large percentage of tweets were written by MD's. I thought that the press, consultants and drug companies were the most active group. I also like the info about ipilimumab being the most talked about drug- and still no Twitter activity from BMS. I'm confident in 2011 or 2012 Twitter activity will become a standard way to filter the most important ASCO presentations".
Martin Fenner, MD, Clinical Fellow in Oncology, Hannover Medical School. @mfenner
"The JuvoLab #ASCO10 report contains a lot of useful information. Some of it is consistent with my subjective experience, but there were also a few surprises in there. I didn't realize that a large percentage of tweets were written by MD's. I thought that the press, consultants and drug companies were the most active group. I also like the info about ipilimumab being the most talked about drug- and still no Twitter activity from BMS. I'm confident in 2011 or 2012 Twitter activity will become a standard way to filter the most important ASCO presentations".
Martin Fenner, MD, Clinical Fellow in Oncology, Hannover Medical School. @mfenner
